Data / Form D filings / Fisher Wallace Laboratories, Inc.
Fisher Wallace Laboratories, Inc.: Form D filings
Fisher Wallace Laboratories, Inc., a biotechnology company in Brooklyn, NY, filed 2 Form D notices with the SEC between 2022 and 2025. The latest, on June 13, 2025, reports an offering of $5 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 630 FLUSHING AVENUE, BOX 104, Brooklyn, NY, 11206
- Phone
- (917) 930-4332
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1787792
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Jul 26, 2022 | New notice | $750,000 | $250,000 | $500,000 | 1 | Jul 3, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kelly Joseph Roman | Executive Officer, Director | |
| Charles Avery Fisher | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Jun 9, 2025 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Fisher Wallace Laboratories, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.